Gonadorelin

What is Gonadorelin?

Gonadorelin is a synthetic copy of gonadotropin-releasing hormone (GnRH), also called LHRH. GnRH is a ten-amino acid hormone made in the hypothalamus that acts on the pituitary gland to release the reproductive hormones LH and FSH.⁵ GnRH is produced by a small population of specialized brain cells whose development and function have been studied for decades.⁴ Its structure was worked out in the early 1970s, work recognized with a share of the 1977 Nobel Prize in Physiology or Medicine.

Injected GnRH was first used as a diagnostic test of the pituitary's ability to release LH and FSH, and later to treat infertility and underactive gonads caused by hypothalamic problems in both men and women.⁷ Gonadorelin was FDA-approved for diagnostic use under the brand name Factrel, but US marketing has been discontinued.

Today, gonadorelin is most often prescribed in compounded form by men's health and testosterone replacement therapy (TRT) clinics, including telehealth services, to help preserve testicular size and function during TRT.

How Gonadorelin works

The brain controls the testes and ovaries through a chain of signals. The hypothalamus releases GnRH in short bursts, the pituitary responds with LH and FSH, and those hormones tell the testes to make testosterone and sperm, or the ovaries to mature eggs. When a man takes testosterone, the brain senses high levels and turns this chain down, so the testes shrink and sperm production falls. Gonadorelin is meant to replace the missing top-level signal.

The catch is timing. The pituitary only responds properly to GnRH delivered in pulses, roughly every one to two hours in normal physiology. Constant exposure has the opposite effect: the pituitary stops responding and LH and FSH fall. That is how long-acting GnRH agonists such as leuprolide work, producing a reversible medical castration used to treat prostate and breast cancer, endometriosis and early puberty.⁷³ Gonadorelin has a half-life of only minutes, which suits pulsatile use. Disrupting the normal GnRH pulse pattern, rather than pulsatile dosing itself, is also linked to hot flushes.¹

What the research shows on Gonadorelin

The evidence for gonadorelin's established uses is solid. As a diagnostic agent, it reliably shows whether the pituitary can release LH and FSH. As a treatment, pulsatile GnRH given through a small pump that delivers a dose every one to two hours can restore puberty, sperm production and ovulation in people whose hypothalamus does not make enough GnRH.⁷

The evidence for the way TRT clinics use it is much weaker. Typical TRT protocols inject gonadorelin under the skin a few times a week, not every couple of hours. In theory each injection produces a short burst of LH and FSH, but it is not clear that occasional bursts are enough to maintain testicular size or sperm production in men whose own GnRH signal is suppressed by testosterone. Randomized trials showing that gonadorelin used this way preserves fertility during TRT are lacking. Human chorionic gonadotropin (hCG), which acts directly on the testes, has more supporting data for that purpose.

Research on the GnRH system has instead moved toward blocking it. Peptide and non-peptide GnRH antagonists were developed to suppress the axis without the initial hormone surge seen with agonists.⁵ Antagonists such as degarelix appear at least as effective as agonists in advanced prostate cancer,⁶ and the oral antagonist relugolix produced higher rates of sustained castration than leuprolide in a phase 3 trial, with fewer major cardiovascular events.² In endometriosis, randomized trials found GnRH agonists as effective as danazol for pain, with side effects from low estrogen such as hot flushes and bone loss.⁸

Studied for: Preservation of testicular function during TRT, Hypogonadotropic hypogonadism, Fertility.

Gonadorelin reference data

Gonadorelin dosage in published research

Open this in the dosage calculator ↗

How Gonadorelin is used in practice

Most gonadorelin prescribed in the US today is compounded. Clinics adopted it widely after hCG moved to regulation as a biologic in 2020, which largely ended routine pharmacy compounding of hCG. Gonadorelin is usually supplied as a powder to mix with bacteriostatic water and injected under the skin two or three times a week, sometimes more often in fertility-focused protocols. Doses and schedules vary widely between clinics, which reflects the lack of trial data rather than careful tailoring.

Clinics often monitor testosterone, estradiol and sometimes LH, and may track testicular size. Men who want to protect fertility should ask for a semen analysis rather than rely on symptoms or testicular size alone.

Because compounded products are not FDA-approved, potency and sterility depend on the pharmacy. Products from research-chemical sellers carry even fewer safeguards. Gonadorelin is prohibited in sport for men.

Gonadorelin risks and side effects

Gonadorelin is generally well tolerated. Reported side effects include injection-site reactions, headache, flushing, nausea and lightheadedness. Rare allergic reactions, including severe ones, have been reported with GnRH products.

The biggest practical risk is using it the wrong way. Dosing that is too frequent or too continuous could suppress rather than stimulate LH and FSH. Testosterone and estrogen also blunt the pituitary's response, which is part of why its benefit during TRT is uncertain. People on long-acting GnRH agonist treatment will not respond to gonadorelin.

Anyone with a hormone-sensitive cancer, such as prostate or certain breast cancers, should not use it unless a specialist directs otherwise, and it should not be used during pregnancy. Relying on gonadorelin when it is not working can also give a false sense of security about fertility.

Reported side effects

Alternatives to Gonadorelin

For men on TRT who want to keep fertility, hCG is the most commonly used and better-studied option, sometimes combined with FSH when sperm counts need restoring. Men actively trying to conceive are often advised to stop testosterone, because TRT itself suppresses sperm production. Clomiphene is sometimes used off-label to raise a man's own testosterone without suppressing fertility.

For hypothalamic causes of low reproductive hormones, specialist centers may use pulsatile GnRH pumps or gonadotropin injections. For prostate cancer, endometriosis and fibroids, where the goal is suppression, approved GnRH agonists such as leuprolide and antagonists such as relugolix are standard.²

Questions for a clinician

• What evidence applies to my situation, and at what level?
• What established alternatives should I consider first?
• What monitoring would be necessary, and how often?